W.R. Berkley (WRB)
(Delayed Data from NYSE)
$57.63 USD
+0.37 (0.65%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $57.69 +0.06 (0.10%) 5:26 PM ET
3-Hold of 5 3
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.63 USD
+0.37 (0.65%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $57.69 +0.06 (0.10%) 5:26 PM ET
3-Hold of 5 3
B Value C Growth D Momentum B VGM
Zacks News
NMI Holdings (NMIH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
NMI Holdings (NMIH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
First American Financial (FAF) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
First American Financial (FAF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Assurant (AIZ) Q3 Earnings Meet, Revenues Miss Estimates
by Zacks Equity Research
Assurant's (AIZ) Q3 results reflect earnings expansion in Global Lifestyle and lower catastrophes in Global Housing.
MetLife (MET) Q3 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
MetLife (MET) Q3 earnings suffer from high expenses, which offset revenue growth.
Allstate (ALL) Beats Earnings and Revenue Estimates in Q3
by Zacks Equity Research
Allstate's (ALL) Q3 earnings reflect increase in premiums, investment income, effect of share buyback and higher expenses.
W.R. Berkley (WRB) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
W.R. Berkley (WRB) Q3 results reflect higher increased net written premium from both the segments and higher operating income.
Insurers Reporting Q3 Earnings on Oct 22: TRV, MTG, WRB
by Zacks Equity Research
Insurers' Q3 earnings are likely to have benefited from improved pricing, reinsurance agreements. However, catastrophe losses and lower interest rate might have acted as partial offsets.
RLI Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
RLI's Q3 earnings reflect increase in gross premium, surge in investment income and underwriting income.
Why the Earnings Surprise Streak Could Continue for W.R. Berkley (WRB)
by Zacks Equity Research
W.R. Berkley (WRB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Progressive (PGR) Q3 Earnings Surpass Estimates, Down Y/Y
by Zacks Equity Research
Progressive (PGR) Q3 earnings reflect improvement in premiums.
W.R. Berkley (WRB) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
W.R. Berkley (WRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's Why Investors Should Buy W.R. Berkley (WRB) Stock
by Zacks Equity Research
W.R. Berkley (WRB) remains poised for growth on operational excellence and growth initiatives.
CNA or WRB: Which Property & Casualty Insurer is a Better Buy?
by Zacks Equity Research
Given a mixed operating backdrop, let's see which stock, CNA Financial (CNA) or W. R. Berkley Corporation (WRB) offers better rewards based on a comparative analysis.
ALL vs. WRB: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALL vs. WRB: Which Stock Is the Better Value Option?
Here's Why You Should Hold Everest Re (RE) in Your Portfolio
by Zacks Equity Research
Everest Re Group (RE) remains poised for growth on risk management ability, capital sufficiency and global presence.
P&C Insurance Industry's Near-Term Prospects Encouraging
by Tanuka De
The property and casualty insurance industry remains well poised on better pricing, solid policyholders' surplus and increasing use of technology.
FAF or WRB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FAF vs. WRB: Which Stock Is the Better Value Option?
First American Financial (FAF) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
First American Financial (FAF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
American Financial to Share More Profits, Hikes Dividend
by Zacks Equity Research
American Financial's (AFG) recent 12.5% hike in dividend marks its intention to enhance shareholders value supported by strong financial position.
W.R. Berkley (WRB) Rises 46% YTD: Will the Rally Continue?
by Zacks Equity Research
W.R. Berkley's (WRB) operational excellence and growth initiatives help the stock continue the bull run.
W.R. Berkley (WRB) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
W.R. Berkley (WRB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why W.R. Berkley (WRB) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does W.R. Berkley (WRB) have what it takes to be a top stock pick for momentum investors? Let's find out.
Allstate (ALL) Estimates Weather Related Losses in July
by Zacks Equity Research
Allstate (ALL) expects to incur $223 million pre-tax catastrophe loss for July, which can be attributed to 10 weather-related events.
FAF vs. WRB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FAF vs. WRB: Which Stock Is the Better Value Option?
W.R. Berkley (WRB) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
W.R. Berkley (WRB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.